Zurueck zur Suche

Reporte zur Charge 4N2PM

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

28Reporte angezeigt
0Todesfaelle
2Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
CA 4 MD 4 NY 3 MI 3 NC 3 CO 3 ND 2 FL 1 VA 1 WA 1 OH 1 MO 1

VAERS 2721358

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

kritisch
Staat
CA
Alter
0,6
Geschlecht
F
Eingang
06.12.2023
Impfdatum
30.11.2023
Beginn
30.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Cardio-respiratory arrest Computerised tomogram head Cyanosis Ejection fraction decreased Enterovirus test positive Human rhinovirus test positive Lung assist device therapy Product administered to patient of inappropriate age Pyrexia Respiratory viral panel Wrong product administered

Symptomtext

On the evening of the day she received her vaccines she had a cyanotic event at home, was brought to the hospital and had a code event after obtaining a head CT. She also had a fever to 39.3C on arrival. She has known aortic stenosis. Her EF which had been normal earlier in the week was down to the 20%s. She was placed on ECMO. Concern for myocarditis vs vaccine adverse reaction. Of note, the RSV vaccine approved for adults and pregnant women was given by mistake along with her other routine 6mo vaccines. (This may be being reported by the clinic that administered the vaccines as well)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardio-respiratory arrest
Hospital-Tage
-
Labordaten
Viral panel positive for rhino-enterovirus
Aktuelle Erkrankungen
Had 1-2 presumed viral URIs in the 1-3 weeks preceding the event
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2603687

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

schwer
Staat
NY
Alter
0,3
Geschlecht
M
Eingang
24.03.2023
Impfdatum
23.03.2023
Beginn
23.03.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Chills Enterovirus test positive Human rhinovirus test positive Seizure

Symptomtext

Rigor vs seizure in the evening after immunizations. Evaluated and observed in ER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
(+) Rhinovirus/enterovirus PCR
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2669534

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

mild
Staat
CA
Alter
-
Geschlecht
M
Eingang
10.08.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pyrexia

Symptomtext

Fever; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of fever in a 1-year-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number 4N2PM) for prophylaxis. On an unknown date, the patient received Pediarix. On an unknown date, 24 hrs after receiving Pediarix, the patient experienced fever (Verbatim: Fever). The outcome of the fever was resolved. It was unknown if the reporter considered the fever to be related to Pediarix and Pediarix Pre-Filled Syringe Device. It was unknown if the company considered the fever to be related to Pediarix and Pediarix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-JUL-2023 The reporter reported that the patient received Pediarix vaccine and 24 hours after received vaccine patient experienced fever. The reporter stated that the fever had resolved now. The reporter did consent to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2665631

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

mild
Staat
FL
Alter
0,2
Geschlecht
M
Eingang
03.08.2023
Impfdatum
01.05.2023
Beginn
01.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fatigue

Symptomtext

Mother reported ( at the 4 month well visit) that infant was extremely tired following immunizations, he would wake up to feed then return to sleep for one week following immunization. He did get PCV, HIB and rotavirus as well, mother attributed reaction to Pertussis part of vaccine after researching vaccine side effects. Mother is now reluctant to get further pertussis vaccines and would like to proceed with one vaccine at a time

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
vitamin D
Allergien
none
Vorherige Impfungen
-

VAERS 2631065

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

mild
Staat
MI
Alter
0,2
Geschlecht
M
Eingang
12.05.2023
Impfdatum
20.04.2023
Beginn
21.04.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dermatitis diaper Diarrhoea Pyrexia Vomiting

Symptomtext

liquid stools, fever, diaper rash, vomiting

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
congestion
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2629846

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

mild
Staat
CA
Alter
0,3
Geschlecht
F
Eingang
10.05.2023
Impfdatum
08.05.2023
Beginn
08.05.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site mass Lethargy Pyrexia

Symptomtext

3 cm X 4 cm indurated erythematous lumps at all 3 injection sites to bilateral thighs found by mom on the evening of 5/8/23. Mom also found her to be feverish and more lethargic on the evening of 5/8/23. Mom medicated her with infant's Tylenol at home and then brought her into see her pediatrician on 5/9/23.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2602321

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

mild
Staat
NC
Alter
0,2
Geschlecht
M
Eingang
23.03.2023
Impfdatum
21.03.2023
Beginn
21.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Lethargy Urticaria

Symptomtext

Hives to bilateral legs/ abdomen and lethargy approximately 2 hours after vaccine administration. EMS called and IM benadryl given. Patient observed in the ED for 2 hours and returned to baseline.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
Patient has been referred to allergy specialist.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2592145

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

mild
Staat
VA
Alter
0,3
Geschlecht
F
Eingang
06.03.2023
Impfdatum
03.03.2023
Beginn
03.03.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Haematochezia Mucous stools Occult blood negative

Symptomtext

Patient developed diarrhea over the 24 hours after receiving vaccines. Over the next 2 days, she had mucous loose stools and one episode of blood-streaked stools. No periods of inconsolability, vomiting, fevers. Feeding well. When she was seen 3 days after the vaccine, she was still having looser, mucous stools but had not had any further bloody stools.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
3/6/2023: Hemoccult stool test- NEGATIVE
Aktuelle Erkrankungen
No known illnesses
Vorgeschichte
N/A
Andere Medikamente
Gripe water
Allergien
NKA
Vorherige Impfungen
-

VAERS 2688648

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
NY
Alter
6,0
Geschlecht
M
Eingang
29.09.2023
Impfdatum
06.09.2023
Beginn
06.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

n/a

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2686534

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
NY
Alter
2,0
Geschlecht
M
Eingang
26.09.2023
Impfdatum
01.09.2023
Beginn
01.09.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

N/A

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2679619

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
WA
Alter
0,6
Geschlecht
M
Eingang
06.09.2023
Impfdatum
15.08.2023
Beginn
15.08.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
SYR / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

No physical adverse reaction, documenting for vaccine error that PedvaxHib administered when it was not due.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2672298

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
OH
Alter
0,1
Geschlecht
M
Eingang
16.08.2023
Impfdatum
09.06.2023
Beginn
10.06.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Immunisation reaction

Symptomtext

Adverse effect of other vaccines and biological substances, initial encounter on 2023-06-10.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Immunisation reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Encounter for routine child health examination NOS
Vorgeschichte
-
Andere Medikamente
None
Allergien
-
Vorherige Impfungen
-

VAERS 2662695

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
CA
Alter
1,3
Geschlecht
M
Eingang
28.07.2023
Impfdatum
28.07.2023
Beginn
28.07.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered Wrong product administered

Symptomtext

An medical assistant (MA) had administered the incorrect medication (Pediarix) to a patient, when the order was for Infanrix. It is understood that what occurred was that the MA pulled infanrix from the cart and gave to the doctor to confirm. Per the doctor, he saw DTaP and did give the approval to administer the medication. The MA first administered the vaccine to the patient, followed by scanning the vaccine, and learned the vaccine administered was the incorrect pne due to a hard stop upon scanning. The MA informed the doctor. The doctor notified the patient's mother that they accidentally gave Pediarix and told her that the patient received an extra Hep B vaccine. The doctor reassured her that this was at a safe interval from previous (6 months administration) and to monitor the patient for side effects of vaccine administration. The patient expressed appreciation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 2657898

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4n2pm

gering
Staat
CO
Alter
1,0
Geschlecht
F
Eingang
18.07.2023
Impfdatum
14.07.2023
Beginn
14.07.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

patient received pediarix instead of Infanrix/ had gotten 3 doses and received Pediarix as 4th dose; patient received pediarix instead of Infanrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 15-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 4n2pm, expiry date 28-MAR-2025) for prophylaxis. Previously administered products included Pediarix (had gotten 3 doses on an unknown date). On 14-JUL-2023, the patient received the 4th dose of Pediarix. On 14-JUL-2023, an unknown time after receiving Pediarix, the patient experienced extra dose administered (Verbatim: patient received pediarix instead of Infanrix/ had gotten 3 doses and received Pediarix as 4th dose) and wrong vaccine administered (Verbatim: patient received pediarix instead of Infanrix). The outcome of the extra dose administered and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 17-Jul-2023 The reporter consented to follow-up. The patient was meant to be Infanrix (4th dose) but Pediarix was given instead, which led to extra dose administered and wrong vaccine administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2653203

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
ND
Alter
0,1
Geschlecht
M
Eingang
06.07.2023
Impfdatum
15.06.2023
Beginn
15.06.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

None.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2648089

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
21.06.2023
Impfdatum
-
Beginn
23.03.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Flulaval, Havrix, Kinrix, Pediarix, Infanrix that was stored at 49.8F x 185.5 hours; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2022-2023 season) (batch number 2YB4G, expiry date 30-JUN-2023) for prophylaxis. Co-suspect products included HAV (Havrix) (batch number 9R5LC, expiry date 02-NOV-2024) for prophylaxis, DTPa-IPV (Kinrix) (batch number 5AY2J, expiry date 10-JUN-2024) for prophylaxis, DTPa-HBV-IPV (Pediarix) (batch number 4N2PM, expiry date 28-MAR-2025) and (batch number 25L32, expiry date 28-MAR-2025) for prophylaxis and DTPa (Infanrix) (batch number 7HM5J, expiry date 18-SEP-2024) and (batch number 7C9NJ, expiry date 10-NOV-2024) for prophylaxis. On an unknown date, the patient received FluLaval Quadrivalent 2022-2023 season, Havrix, Kinrix and Pediarix. On an unknown date, the patient received Infanrix. On 23-MAR-2023, an unknown time after receiving FluLaval Quadrivalent 2022-2023 season, Havrix, Kinrix, Pediarix and Infanrix, the patient experienced incorrect storage of drug (Verbatim: Flulaval, Havrix, Kinrix, Pediarix, Infanrix that was stored at 49.8F x 185.5 hours). The outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:14-JUN-2023 The health care professional (HCP) reported administration of Flulaval, Havrix, Kinrix, Pediarix, Infanrix that was stored at 49.8F x 185.5 hours (per audit, multiple excursions from March 23, 2023 - May 18, 2023). It was unknown how many patients and which vaccines were administered during this period or up until the current date. The reporter did not consent to follow up. The vaccines were stored wrongly which led to Incorrect storage of drug.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2643087

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
MO
Alter
1,3
Geschlecht
U
Eingang
08.06.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

received pediarix instead of infanrix inadvertently; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 15-month-old patient who received DTPa-HBV-IPV (Pediarix) (batch number 4N2PM, expiry date 28-MAR-2025) for prophylaxis. On an unknown date, the patient received Pediarix (right thigh). On an unknown date, an unknown time after receiving Pediarix, the patient experienced wrong vaccine administered (Verbatim: received pediarix instead of infanrix inadvertently). The outcome of the wrong vaccine administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 6-Jun-2023 The reporter consented to follow-up. The patient received a dose of Pediarix instead of Infanrix inadvertently, which led to wrong vaccine administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2636877

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
NC
Alter
0,5
Geschlecht
M
Eingang
25.05.2023
Impfdatum
02.05.2023
Beginn
02.05.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product preparation error

Symptomtext

Wrong covid vaccine preparation given. No adverse outcome.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2636711

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
NC
Alter
0,5
Geschlecht
F
Eingang
25.05.2023
Impfdatum
04.05.2023
Beginn
04.05.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Wrong vaccine given, no adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Vitamin D
Allergien
none known
Vorherige Impfungen
-

VAERS 2634784

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
ND
Alter
0,3
Geschlecht
F
Eingang
22.05.2023
Impfdatum
16.05.2023
Beginn
16.05.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Faeces discoloured Infant irritability Mucous stools Occult blood positive Ultrasound abdomen normal Urinary system X-ray Urinary tract imaging normal

Symptomtext

Last 5/16/23 around 1:30PM mom called our office and informed us that patient had reddish mucus in the stool after their appointment with us. 2 hours later, mom informed us and described it as "strawberry jelly mucus". No fever, no vomiting, abdomen was soft, patient a little bit fussy. Talked the situation to the provider. He spoke to parents about the concerns and plan. The provider ordered stat ultrasound abdomen and stat occult blood screen. But the patient ended up being seen in the ER d/t almost past office hours of the clinic and occult blood sample was not accepted at the lab because it has to be in a stool container and that sample may be contaminated with urine. Patient was transferred to facility

Weitere VAERSDATA-Felder
Praegender Schweregrund
Faeces discoloured
Hospital-Tage
1,0
Labordaten
US Abdomen - negative for intussusception Occult blood screen - Positive Patient was transfered to Facility Facility's Dx: could be r/t viral gastroenteritis 1 day admission KUB - negative US Abdomen - negative
Aktuelle Erkrankungen
Eczema Gastroesophageal reflux Ingrowing nail, right great toe
Vorgeschichte
none
Andere Medikamente
Infant's Tylenol
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 2631069

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
MI
Alter
0,2
Geschlecht
M
Eingang
12.05.2023
Impfdatum
02.05.2023
Beginn
02.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Haematochezia

Symptomtext

blood in stools

Weitere VAERSDATA-Felder
Praegender Schweregrund
Haematochezia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Vitamin D drops
Allergien
none
Vorherige Impfungen
-

VAERS 2626648

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
MD
Alter
0,5
Geschlecht
F
Eingang
04.05.2023
Impfdatum
21.04.2023
Beginn
21.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

CDC revised administration of Covid vaccine by eliminating the monovalent and advising to administer with first dose bivalent. Days later it was advised to increase the initial dose of 6 months- 5 years bivalent Moderna to the 6 years and up. This vaccine was administered prior to the increase being communicated to us. It was only recognized when we attended a Moderna information session. This was not communicated until April 28th through the local Health Dept.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2626629

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
MD
Alter
0,5
Geschlecht
M
Eingang
04.05.2023
Impfdatum
25.04.2023
Beginn
25.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

CDC revised administration of Covid vaccine by eliminating the monovalent and advising to administer with first dose bivalent. Days later it was advised to increase the initial dose of 6 months- 5 years bivalent Moderna to the 6 years and up. This vaccine was administered prior to the increase being communicated to us. It was only recognized when we attended a Moderna information session. This was not communicated until April 28th through the Department of Health

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2626627

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
MD
Alter
0,5
Geschlecht
F
Eingang
04.05.2023
Impfdatum
25.04.2023
Beginn
25.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

CDC revised administration of Covid vaccine by eliminating the monovalent and advising to administer with first dose bivalent. Days later it was advised to increase the initial dose of 6 months- 5 years bivalent Moderna to the 6 years and up. This vaccine was administered prior to the increase being communicated to us. It was only recognized when we attended a Moderna information session. This was not communicated until April 28th through the Department

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2626623

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
MD
Alter
0,5
Geschlecht
M
Eingang
04.05.2023
Impfdatum
22.04.2023
Beginn
22.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

CDC revised administration of Covid vaccine by eliminating the monovalent and advising to administer with first dose bivalent. Days later it was advised to increase the initial dose of 6 months- 5 years bivalent Moderna to the 6 years and up. This vaccine was administered prior to the increase being communicated to us. It was only recognized when we attended a Moderna information session. This was not communicated until April 28th through the Department of Health.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2626477

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
MI
Alter
0,3
Geschlecht
F
Eingang
04.05.2023
Impfdatum
03.05.2023
Beginn
03.05.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product dose omission in error Product preparation error

Symptomtext

patient due for Rotavirus vaccine but was only given sterile diluent. pt did not get live virus. attempting to notify parents, will schedule for a nurse visit so patient can get dose that was missed . Unit manager and PCP notified.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product dose omission in error
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
cholecalciferol 400 IU
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2625836

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
WI
Alter
0,5
Geschlecht
F
Eingang
03.05.2023
Impfdatum
28.04.2023
Beginn
28.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Underdose

Symptomtext

Patient received COVID-19 Moderna Bivalent 6 months - 5 years (dark pink cap with yellow label) 0.2 ml as dose #1 instead of receiving COVID-19 Moderna Bivalent 6 months - 5 years (dark blue cap with grey label) 0.25 ml

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2603655

GLAXOSMITHKLINE BIOLOGICALS · DTAP + HEPB + IPV (PEDIARIX) · Charge 4N2PM

gering
Staat
CO
Alter
11,0
Geschlecht
F
Eingang
24.03.2023
Impfdatum
10.03.2023
Beginn
10.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

11 year old patient was given Pediarix; 11 year old patient was given Pediarix instead of Boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 4N2PM, expiry date 28-MAR-2025) for prophylaxis. On 10-MAR-2023, the patient received Pediarix. On 10-MAR-2023, an unknown time after receiving Pediarix, the patient experienced inappropriate age at vaccine administration (Verbatim: 11 year old patient was given Pediarix) and wrong vaccine administered (Verbatim: 11 year old patient was given Pediarix instead of Boostrix). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-MAR-2023 The reporter was a medical assistant. The reporter was consented to follow up. The 11 year old patient was given Pediarix instead of Boostrix which led to inappropriate age at vaccine administration and wrong vaccine administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-